Internal mammary sentinel lymph node biopsy in breast cancer: accurate staging and individualized treatment
The aim of this study was to determine the impact of routinely performed internal mammary sentinel lymph node biopsy (IM-SLNB) on the staging and treatment, and to analyze the success rate, complications and learning curve. All patients with biopsy-proven breast cancer who underwent sentinel lymph n...
Saved in:
Published in | Zhōnghuá zhŏngliú zázhì Vol. 38; no. 1; pp. 42 - 47 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | Chinese |
Published |
China
01.01.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The aim of this study was to determine the impact of routinely performed internal mammary sentinel lymph node biopsy (IM-SLNB) on the staging and treatment, and to analyze the success rate, complications and learning curve.
All patients with biopsy-proven breast cancer who underwent sentinel lymph node biopsy between 2012 and 2014 were included in a prospective analysis. Internal mammary sentinel lymph node biopsy (IM-SLNB) was performed in all patients with IM-SLN visualized on preoperative lymphoscintigraphy and/or detected by intraoperative gamma probe detection. The adjuvant treatment plan was adjusted according to the current guidelines.
In a total of 349 patients, 249 patients (71.1%) showed internal mammary drainage. IM-SLNB was performed in 153 patients with internal mammary drainage, with a success rate of IM-SLNB of 97.4% (149/153). Pleural lesion and internal mammary artery bleeding were found in 7.2% and 5.2% patients, respectively. In 8.1% of patients (12/149) the IM-SLN was tumor positive. In th |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0253-3766 |
DOI: | 10.3760/cma.j.issn.0253-3766.2016.01.009 |